Machine Learning Analysis Reveals Biomarkers for the Detection of Neurological Diseases

It is critical to identify biomarkers for neurological diseases (NLDs) to accelerate drug discovery for effective treatment of patients of diseases that currently lack such treatments. In this work, we retrieved genotyping and clinical data from 1,223 UK Biobank participants to identify genetic and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Simon, Arif, Muhammad, Song, Xiya, Uhlén, Mathias, Mardinoglu, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194858/
https://www.ncbi.nlm.nih.gov/pubmed/35711735
http://dx.doi.org/10.3389/fnmol.2022.889728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194858/
https://www.ncbi.nlm.nih.gov/pubmed/35711735
http://dx.doi.org/10.3389/fnmol.2022.889728

Ejemplares similares